|
| FT.com - Drugs and Healthcare
FT.com - Drugs and Healthcare
The maker of drug delivery systems, Skyepharma, is close to an agreement to renegotiate its bonds, as it announced a reduction in losses and increased revenues
Profits at BUPA have been dented by its exit from the Irish market last year, although its core insurance business continues to grow
Britain's poor need to be helped to healthier habits. More than new hospitals, preventative campaigns are what the UK needs to close its health gap
A biological breakthrough could lead to a cure for diabetes and has profound implications for regenerative medicine – replacing diseased or injured tissues with new ones in good working order
Western clinics and medical schools are helping to plug the Gulf's healthcare gap
The Anglo-American group's move underlines how the defensive qualities of the psychiatric care market are proving increasingly attractive to buy-out investors
Drugmaker says Alpharma rejected a $1.4bn unsolicited takeover offer it made this month, prompting the suitor to reveal details of the bid publicly
The number of bidders for Elan Drug Technologies, a subsidiary of the Irish pharmaceuticals company, has narrowed after Cinven dropped out of the auction
The UK medical watchdog chairman claims that pharmaceuticals executives had no interest in making cheaper drugs because their bonuses depended on producing earnings growth
GeneThera, which is based in Colorado, had offered 35p a share for the British biotechnology company, or three-and-a-half times Friday's closing price
Newsfeed display by CaRP |
|
|